Home

Insights

Procter & Gamble Health Ltd P/E Ratio

Procter & Gamble Health Ltd P/E Ratio

download
stocks purchased

₹ 0.1 Cr

Volume transacted

stocks purchased

0.3 K

stocks traded

Image

Procter & Gamble Health Ltd

NSE: PGHL

PE

36.8

Last updated : 21 May 10:41 AM

Key Highlights

    The P/E Ratio of Procter & Gamble Health Ltd is 36.8 as of 21 May 10:41 AM .a1#The P/E Ratio of Procter & Gamble Health Ltd changed from 39.9 to 38 over 4 quarters. This represents a CAGR of -4.76% a1#The Latest Trading Price of Procter & Gamble Health Ltd is ₹ 4773 as of 21 May 16:01 .a1#The PE Ratio of Pharmaceuticals Industry has changed from 28.7 to 27.7 in 5 years. This represents a CAGR of -0.71%a1# The PE Ratio of Automobile industry is 27.2. The PE Ratio of Finance industry is 13.6. The PE Ratio of IT - Software industry is 27.9. The PE Ratio of Pharmaceuticals industry is 27.7. The PE Ratio of Retail industry is 94.8. The PE Ratio of Textiles industry is 21.1. In 2023a1#The Market Cap of Procter & Gamble Health Ltd changed from ₹ 6751 crore to ₹ 8713 crore over 4 quarters. This represents a CAGR of 29.06% a1#The Revenue of Procter & Gamble Health Ltd changed from ₹ 270.17 crore to ₹ 254.75 crore over 8 quarters. This represents a CAGR of -2.90% a1#The EBITDA of Procter & Gamble Health Ltd changed from ₹ 71.12 crore to ₹ 69.71 crore over 8 quarters. This represents a CAGR of -1.00% a1#The Net Profit of Procter & Gamble Health Ltd changed from ₹ 51.16 crore to ₹ 46.56 crore over 8 quarters. This represents a CAGR of -4.60% a1#The Dividend Payout of Procter & Gamble Health Ltd changed from 150.27 % to 44.49 % over 4 quarters. This represents a CAGR of -70.39% a1#

Open Demat Account

Lead form image

+91

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

*By signing up you agree to our terms & conditions

×

P/E Ratio Over Time

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

P/E Ratio Over Time

Period
June 202039.9
June 202152.5
June 202236.1
June 202338

Fundamental Metrics

Market Cap

7,992 Cr

EPS

128.9

P/E Ratio (TTM) *

36.8

P/B Ratio (TTM) *

9.8

Day’s High

4899.9

Day’s Low

4740.0

DTE *

0.0

ROE *

28.1

52 Week High

5640.0

52 Week Low

4640.3

ROCE *

38.1

* All values are consolidated

* All values are consolidated

Image

Procter & Gamble Health Ltd

NSE: PGHL

PRICE

4773.8

-41.25(-0.86%)

stock direction

Last updated : 21 May 16:01

×

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Share price Over Time

1M

1Y

3Y

5Y

* All values are in Rupees

SWOT Analysis Of Procter & Gamble Health Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

Asset Value vs Market Value

Market Value

7,884

Asset Value

821

8.6 X

Value addition

* All values are in Rupees

PE Ratio Over Market Cap

Key Valuation Metric

Earnings

214 Cr

36.8 X

PE Ratio

Market Cap

₹7883Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio

PS Ratio

PB Ratio

Earnings

214 Cr

36.8 X

PE Ratio

Market Cap

₹7883Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Procter & Gamble Health Ltd PE Ratio Calculation

  • The Price-to-Earnings (PE) ratio, also known as the P/E Ratio, is a fundamental financial metric used to assess the valuation of a company's stock in relation to its earnings performance. For Procter & Gamble Health Ltd, the PE Ratio is calculated as follows:

P/E Ratio

=

Market Capitalization

Net Income

  • Given the current market conditions, Procter & Gamble Health Ltd's Share Price stands at 4773.8. The Earnings per Share (Diluted) for the trailing twelve months (TTM) ending in 2024-05-21T16:01:00 is 128.93. Substituting the values into the formula, PE Ratio becomes as follows: PE Ratio = 4773.8/ 128.93= 36.84.

P/E Ratio

=

Stock Price

Earning Per Share

  • This indicates that Procter & Gamble Health Ltd's stock is trading at approximately 36.84 times its earnings per share for the trailing twelve months. Alternatively, the PE Ratio can also be computed using the company's overall financial performance: PE Ratio = Market Cap / Net Income. Where Market Cap represents the total market capitalization of the company, and Net Income signifies the total earnings after expenses and taxes.

Understanding Procter & Gamble Health Ltd’s PE Ratio (BSE: PGHL)

    The Price-to-Earnings (PE) ratio, used to assess Procter & Gamble Health Ltd's stock (BSE: PGHL), indicates how many years it would take for the company to earn back the stock price. If a company earns ₹2 per share annually and its stock trades at ₹30, the PE ratio is 15, signifying a 15-year payback period assuming steady earnings. Earnings fluctuate, affecting the payback period, Growing earnings shorten the recovery time while declining earnings extend it. Shareholders favor shorter payback periods, preferring lower PE stocks. Among stocks with the same PE ratio, faster-growing businesses are preferred. A company with losses makes the PE ratio meaningless. Peter Lynch introduced the PEG ratio to compare stocks with different growth rates, dividing the PE ratio by the growth rate. A company is considered fairly valued when its PE ratio matches its growth rate. The PE ratio, applicable across industries, measures stock valuation based on earnings power. It indicates how quickly an investment can be recouped. Unlike the PB ratio, which assesses valuation based on the balance sheet, the PE ratio focuses on earnings. Overall, the PE ratio provides insights into stock valuation, aligning with investors' preference for faster returns.

×

Market Cap Over Time

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Market Cap Over Time

Period
June 20206752
June 20219286
June 20226951
June 20238714

* All values are a in crore

×

Revenue Over Time

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Revenue Over Time

Period
Dec '22270
Jun '22301
Sep '22315
Dec '23326
Mar '22307
Jun '23311
Sep '23315
Dec '24255

* All values are a in crore

×

EBITDA Over Time

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

EBITDA Over Time

Period
Dec '2271
Jun '2294
Sep '22113
Dec '2385
Mar '2251
Jun '2395
Sep '23107
Dec '2470

* All values are a in crore

×

Net Profit Over Time

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Net Profit Over Time

Period
Dec '2251
Jun '2264
Sep '2277
Dec '2359
Mar '2230
Jun '2366
Sep '2372
Dec '2447

* All values are a in crore

×

Dividend Payout Over Time

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Dividend Payout Over Time

Period
June 2020150
June 2021122
June 202245
June 202344

* All values are a in %

About Procter & Gamble Health Ltd

About Procter & Gamble Health Ltd

    Procter & Gamble Health Limited (formerly Merck Limited), is an Indian-based company principally engaged in the business of manufacturing and marketing of pharmaceuticals and chemicals. The company is the supplier of Pharmaceutical Chemicals, Formulated Chemical Products, Chemicals, Industrial Chemicals, Chemicals, Pharmaceutical Industry, and Chemical Products. The Pharmaceuticals business comprises of Ethicals used in the treatment of Cardiovascular and Metabolic diseases & Vitamin-based formulations and Consumer Health Care Products. In December 2000, the company acquired the Livogen brand from Glaxo India for a consideration of Rs 8 crore. They launched new drug under the brand name of 'Acrobat', while Kopran launched the product under the brand name of 'Ziflam'. In the year 2006, the company expanded the production capacity of Bulk Drugs by 33 tonnes to 351 tonnes.

Procter & Gamble Health Ltd News Hub

News

Procter & Gamble Health to declare Quarterly Result

Procter & Gamble Health will hold a meeting of the Board of Directors of the Company on 2 ...

Read more

28 Mar 2024 10:29

News

Board of Procter & Gamble Health recommends interim dividend

Procter & Gamble Health announced that the Board of Directors of the Company at its meetin...

Read more

07 Feb 2024 11:47

News

Board of Procter & Gamble Health recommends special dividend

Procter & Gamble Health announced that the Board of Directors of the Company at its meetin...

Read more

07 Feb 2024 11:47

News

Procter & Gamble Health to table results

Procter & Gamble Health will hold a meeting of the Board of Directors of the Company on 6 ...

Read more

13 Jan 2024 11:55

News

Procter & Gamble Health to hold board meeting

Procter & Gamble Health will hold a meeting of the Board of Directors of the Company on 3 ...

Read more

28 Sep 2023 12:01

News

P&G to shut its injection production at Goa facility from 30 Sept

“Discontinuation of production at its plant in Goa, shall not have an impact on continuity...

Read more

27 Sep 2023 11:00

Product Composition by Percentage (Revenue)

FAQs for PE of Procter & Gamble Health Ltd

What is Procter & Gamble Health Ltd current share price?

The current market price of Procter & Gamble Health Ltd as of May 21, 2024 is ₹4773.80.

What is Procter & Gamble Health Ltd's market cap?

Procter & Gamble Health Ltd's market capitalisation stood at ₹7,883 Cr as of May 21, 2024

What are Procter & Gamble Health Ltd's total net assets?

According to Procter & Gamble Health Ltd's most recent financial filings, the company's net assets total ₹821.4 Cr.

Is Procter & Gamble Health Ltd making a profit or loss?

Procter & Gamble Health Ltd's net Profit as of May 21, 2024 is close to ₹214 Cr.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199